Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands zur epimakulären Brachytherapie bei altersbedingter Makuladegeneration

Schlüsselwörter

altersbedingte Makuladegeneration - Radiotherapie

Key words

age related macular Degeneration - radiation treatment

• Literatur

• 1 Neue Aspekte in der Therapie der neovaskulären altersabhangigen Makuladegeneration. Aktuelle Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft und des Berufsverbands der Augenärzte Deutschlands e. V. (Stand: März 2009). Ophthalmologe 2009; 106: 457-464
• 2 Finger PT, Berson A, Ng T et al. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999; 127: 170-177
• 3 Zambarakji HJ, Lane AM, Ezra E et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 2012-2019
• 4 Schilling H, Sauerwein W, Lommatzsch A et al. Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol 1997; 81: 267-273
• 5 Scott TA, Augsburger JJ, Brady LW et al. Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal deta chment. Retina 1991; 11: 389-393
• 6 Timke C, Zieher H, Roth A et al. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 2008; 14: 2210-2219
• 7 Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 2007; 12: 465-477
• 8 Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993; 77: 265-273
• 9 Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2010; 5: CD004004
• 10 Hanlon J, Lee C, Chell E et al. Kilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective dose. Med Phys 2009; 36: 3671-3681
• 11 Jaakkola A, Heikkonen J, Tommila P et al. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology 2005; 112: 567-573
• 12 Jaakkola A, Heikkonen J, Tommila P et al. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1998; 236: 24-30
• 13 Holmes SM, Micka JA, DeWerd LA. Investigation of a 90Sr/90Y source for intra-ocular treatment of wet age-related macular degeneration. Med Phys 2009; 36: 4370-4378
• 14 Hart PM, Chakravarthy U, Mackenzie G et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 2002; 120: 1029-1038
• 15 Gertner M, Chell E, Pan KH et al. Stereotactic targeting and dose verification for age-related macular degeneration. Med Phys 2010; 37: 600-606
• 16 Moshfeghi DM, Kaiser PK, Gertner M. Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol 2011; 95: 185-188
• 17 Petrarca R, Jackson TL. Radiation therapy for neovascular age-related macular degeneration. Clin Ophthalmol 2011; 5: 57-63
• 18 Finger PT, Gelman YP, Berson AM et al. Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study. Br J Ophthalmol 2003; 87: 1497-1503
• 19 Saric B, Sikic J, Katusic D et al. Brachytherapy – optional treatment for choroidal neovascularization secondary to age-related macular degeneration. Coll Antropol 2001; 25 Suppl: 89-96
• 20 Kirwan JF, Constable PH, Murdoch IE et al. Beta irradiation: new uses for an old treatment: a review. Eye 2003; 17: 207-215
• 21 Hokkanen J, Heikkonen J, Holmberg P. Theoretical calculations of dose distributions for beta-ray eye applicators. Med Phys 1997; 24: 211-213
• 22 Avila MP, Farah ME, Santos A et al. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. Br J Ophthalmol 2009; 93: 305-309
• 23 Avila MP, Farah ME, Santos A et al. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD. Retina 2009; 29: 157-169
• 24 Archer DB, Gardiner TA. Ionizing radiation and the retina. Curr Opin Ophthalmol 1994; 5: 59-65
• 25 Parsons JT, Bova FJ, Fitzgerald CR et al. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30: 765-773
• 26 Gunduz K, Shields CL, Shields JA et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999; 117: 609-614
• 27 Mauget-Faysse M, Coquard R, Francais-Maury C et al. Radiothérapie dans la dégénérescence maculaire liée a l’age: facteurs de risque de survenue des complications, prévention et traitement des effets secondaires. J Fr Ophtalmol 2000; 23: 127-136
• 28 Kumar B, Palimar P. Accelerated radiation retinopathy in diabetes and pregnancy. Eye 2000; 14 (01) 107-108
• 29 Logani S, Cho AS, Ali BH et al. Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line. Am J Ophthalmol 1995; 120: 506-510
• 30 Chakravarthy U. Radiotherapy for choroidal neovascularisation of age-related macular degeneration: a fresh perspective. Eye 2000; 14 (02) 151-154
• 31 Rizzo S, Belting C, Genovesi-Ebert F et al. Incidence of retinal detachment after small-incision, sutureless pars plana vitrectomy compared with conventional 20-gauge vitrectomy in macular hole and epiretinal membrane surgery. Retina 2010; 30: 1065-1071
• 32 Laude A, Tan LE, Wilson CG et al. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res 2010; 29: 466-475